Please select a Capability in order to start your service request.
Apr 8, 2019
BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion
Mar 26, 2019
BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification
Mar 21, 2019
BD Statement on Paclitaxel-Coated Devices
Mar 14, 2019
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
Feb 13, 2019
BD WavelinQ™ 4F EndoAVF System Receives 510(k) Clearance from U.S. Food and Drug Administration
Feb 5, 2019
BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance
Jan 24, 2019
BD Nano™ Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration
Dec 20, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX™ enteric viral panel, a molecular diagnostic test for the direct qualitative detection and differentiation of enteric viral pathogens that cause viral gastroenteritis.
Dec 11, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL.
Nov 29, 2018
Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting